Organogenesis Holdings Inc. is a regenerative medicine company focused on the development, manufacture, and commercialization of solutions for advanced wound care, surgical, and sports medicine markets. The company offers a portfolio of regenerative products designed to address patient needs across the continuum of care. Its operations include providing bio-active wound healing and soft tissue regeneration products, as well as surgical biologics for orthopedics and spine applications. Organogenesis serves healthcare providers and patients primarily in the United States.
- Website
- www.organogenesis.com
- Issuer profile
- All listings